YH
Yanting Hu

Publications (2)

Dual PI3K/mTOR inhibitor BEZ235 as a promising therapeutic strategy against paclitaxel-resistant gastric cancer via targeting PI3K/Akt/mTOR pathway
Article scientifique · 2018
Gimatecan exerts potent antitumor activity against gastric cancer in vitro and in vivo via AKT and MAPK signaling pathways
Article scientifique · 2017

Domaines principaux

Sciences de la vie et biotechnologies2

Statistiques

Consultations8
Téléchargements0